The Association for Research in Vision and Ophthalmology ARVO 2021 Annual Meeting is being presented in a virtual format for 2021 from May 1 to 7. All paper and poster presentations will be available to the public when the Annual Meeting Virtual Platform launches on Saturday, May 1 at 6:45am and will remain available until the site closes on June 30. All presenter files will be available for attendees to download, including poster files.

Two abstracts related to GenSight Biologics’ product candidates are accepted for platform presentation.


LUMEVOQ® (GS010; lenadogene nolparvovec), for the treatment of Leber Hereditary Optic Neuropathy (LHON)

Abstract Title:  Evaluation of the efficacy of rAAV2/2-ND4 gene therapy for Leber hereditary optic neuropathy compared with the natural history

Presenting AuthorDr. Patrick Yu-Wai Man, Senior Lecturer and Honorary Consultant Ophthalmologist at the University of Cambridge, Moorfields Eye Hospital, and the UCL Institute of Ophthalmology, London (UK)


GS030 – Optogenetics in Retinitis Pigmentosa (RP)

Abstract Title:  Optogenetic GS030 Therapy in Subjects with Retinitis Pigmentosa: Safety and Tolerability Up to Two Years After Treatment Administration in the Phase 1/2a PIONEER Study

Presenting AuthorDr Joseph Martel, Assistant Professor of Ophthalmology Retina and Vitreous Servious, UPMC Eye Center – Eye & Ear Institute, Pittsburg, PA (US)